Analysis of clinical and molecular features of MDS patients with complex karyotype in China-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Analysis of clinical and molecular features of MDS patients with complex karyotype in China

Published:2019-03 Issue: Volume:75 Page:13-19
ISSN:1079-9796
Container-title:Blood Cells, Molecules, and Diseases
language:en
Short-container-title:Blood Cells, Molecules, and Diseases

Author:

Ren Yanling,Mei Chen,Ye Li,Luo Yingwan,Zhou Xinping,Yang Haiyang,Lin Peipei,Xu Weilai,Ma Liya,Jin Jie,Tong Hongyan

Funder

National Natural Science Foundation of China

Zhejiang Medical and Health Science and Technology

Publisher

Elsevier BV

Subject

Cell Biology,Hematology,Molecular Biology,Molecular Medicine

Reference31 articles.

1. Myelodysplastic syndromes;Nimer;Blood,2008

2. Myelodysplastic syndromes: 2014 update on diagnosis, risk-stratification, and management;Garciamanero;Am. J. Hematol.,2015

3. International scoring system for evaluating prognosis in myelodysplastic syndromes;Greenberg;Blood,1997

4. Revised international prognostic scoring system for myelodysplastic syndromes;Greenberg;Blood,2012

5. Clonal diversity of recurrently mutated genes in myelodysplastic syndromes;Walter;Leukemia,2013

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Myeloid sarcoma in JAK2-positive myelodysplastic neoplasms with fibrosis: a case report and literature review;Journal of International Medical Research;2024-08

2. Clinical outcomes and characteristics of patients with TP53 -mutated myelodysplastic syndromes;Hematology;2023-03-09

3. Predictive values of mutational variant allele frequency in overall survival and leukemic progression of myelodysplastic syndromes;Journal of Cancer Research and Clinical Oncology;2022-01-10

4. Clinical Characteristics, Prognosis, and Treatment Strategies of TP53 Mutations in Myelodysplastic Syndromes;Clinical Lymphoma Myeloma and Leukemia;2021-09

5. Allogeneic stem cell transplantation may overcome the adverse impact of myelofibrosis on the prognosis of myelodysplastic syndrome;Experimental Hematology & Oncology;2021-08-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3